These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38798094)

  • 1. A radiomics-based nomogram may be useful for predicting telomerase reverse transcriptase promoter mutation status in adult glioblastoma.
    Li Y; Chen L; Huang L; Li X; Huang Q; Tang L; Huang Z; Zhu L; Li T
    Brain Behav; 2024 May; 14(5):e3528. PubMed ID: 38798094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep Learning Radiomics for the Assessment of Telomerase Reverse Transcriptase Promoter Mutation Status in Patients With Glioblastoma Using Multiparametric MRI.
    Zhang H; Zhang H; Zhang Y; Zhou B; Wu L; Lei Y; Huang B
    J Magn Reson Imaging; 2023 Nov; 58(5):1441-1451. PubMed ID: 36896953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric MRI-based fusion radiomics for predicting telomerase reverse transcriptase (TERT) promoter mutations and progression-free survival in glioblastoma: a multicentre study.
    Zhang H; Zhang H; Zhang Y; Zhou B; Wu L; Yang W; Lei Y; Huang B
    Neuroradiology; 2024 Jan; 66(1):81-92. PubMed ID: 37978079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-parameter MRI based radiomics nomogram for predicting telomerase reverse transcriptase promoter mutation and prognosis in glioblastoma.
    Chen L; Chen R; Li T; Tang C; Li Y; Zeng Z
    Front Neurol; 2023; 14():1266658. PubMed ID: 37830090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A radiomics feature-based nomogram to predict telomerase reverse transcriptase promoter mutation status and the prognosis of lower-grade gliomas.
    Lu J; Li X; Li H
    Clin Radiol; 2022 Aug; 77(8):e560-e567. PubMed ID: 35595562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A radiomics nomogram based on multiparametric MRI might stratify glioblastoma patients according to survival.
    Zhang X; Lu H; Tian Q; Feng N; Yin L; Xu X; Du P; Liu Y
    Eur Radiol; 2019 Oct; 29(10):5528-5538. PubMed ID: 30847586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A radiomics-clinical nomogram for preoperative prediction of IDH1 mutation in primary glioblastoma multiforme.
    Su X; Sun H; Chen N; Roberts N; Yang X; Wang W; Li J; Huang X; Gong Q; Yue Q
    Clin Radiol; 2020 Dec; 75(12):963.e7-963.e15. PubMed ID: 32921406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritumoral Radiomics for Identification of Telomerase Reverse Transcriptase Promoter Mutation in Patients With Glioblastoma Based on Preoperative MRI.
    Zhang H; Zhou B; Zhang H; Zhang Y; Lei Y; Huang B
    Can Assoc Radiol J; 2024 Feb; 75(1):143-152. PubMed ID: 37552107
    [No Abstract]   [Full Text] [Related]  

  • 9. Glioblastoma and Solitary Brain Metastasis: Differentiation by Integrating Demographic-MRI and Deep-Learning Radiomics Signatures.
    Zhang Y; Zhang H; Zhang H; Ouyang Y; Su R; Yang W; Huang B
    J Magn Reson Imaging; 2024 Sep; 60(3):909-920. PubMed ID: 37955154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive Prediction of TERT Promoter Mutations in High-Grade Glioma by Radiomics Analysis Based on Multiparameter MRI.
    Tian H; Wu H; Wu G; Xu G
    Biomed Res Int; 2020; 2020():3872314. PubMed ID: 32509858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
    Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z
    Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conventional magnetic resonance imaging-based radiomic signature predicts telomerase reverse transcriptase promoter mutation status in grade II and III gliomas.
    Jiang C; Kong Z; Zhang Y; Liu S; Liu Z; Chen W; Liu P; Liu D; Wang Y; Lyu Y; Zhao D; Wang Y; You H; Feng F; Ma W
    Neuroradiology; 2020 Jul; 62(7):803-813. PubMed ID: 32239241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive prediction of IDH mutation status in gliomas using preoperative multiparametric MRI radiomics nomogram: A mutlicenter study.
    Lu J; Xu W; Chen X; Wang T; Li H
    Magn Reson Imaging; 2023 Dec; 104():72-79. PubMed ID: 37778708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative prediction of histopathological grading in patients with chondrosarcoma using MRI-based radiomics with semantic features.
    Li X; Zhang J; Leng Y; Liu J; Li L; Wan T; Dong W; Fan B; Gong L
    BMC Med Imaging; 2024 Jul; 24(1):171. PubMed ID: 38992609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sub-region based radiomics analysis for prediction of isocitrate dehydrogenase and telomerase reverse transcriptase promoter mutations in diffuse gliomas.
    Zhang H; Ouyang Y; Zhang H; Zhang Y; Su R; Zhou B; Yang W; Lei Y; Huang B
    Clin Radiol; 2024 May; 79(5):e682-e691. PubMed ID: 38402087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomics Analysis Based on Magnetic Resonance Imaging for Preoperative Overall Survival Prediction in Isocitrate Dehydrogenase Wild-Type Glioblastoma.
    Wang S; Xiao F; Sun W; Yang C; Ma C; Huang Y; Xu D; Li L; Chen J; Li H; Xu H
    Front Neurosci; 2021; 15():791776. PubMed ID: 35153659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal MRI-based radiomic nomogram for predicting telomerase reverse transcriptase promoter mutation in IDH-wildtype histological lower-grade gliomas.
    Huo X; Wang Y; Ma S; Zhu S; Wang K; Ji Q; Chen F; Wang L; Wu Z; Li W
    Medicine (Baltimore); 2023 Dec; 102(51):e36581. PubMed ID: 38134061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A radiomics nomogram may improve the prediction of IDH genotype for astrocytoma before surgery.
    Tan Y; Zhang ST; Wei JW; Dong D; Wang XC; Yang GQ; Tian J; Zhang H
    Eur Radiol; 2019 Jul; 29(7):3325-3337. PubMed ID: 30972543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomics signature: A potential biomarker for the prediction of MGMT promoter methylation in glioblastoma.
    Xi YB; Guo F; Xu ZL; Li C; Wei W; Tian P; Liu TT; Liu L; Chen G; Ye J; Cheng G; Cui LB; Zhang HJ; Qin W; Yin H
    J Magn Reson Imaging; 2018 May; 47(5):1380-1387. PubMed ID: 28926163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram of magnetic resonance imaging (MRI) histogram analysis to predict telomerase reverse transcriptase promoter mutation status in glioblastoma.
    Zhang B; Zhou Q; Xue C; Ke X; Zhang P; Han T; Deng L; Jing M; Zhou J
    Quant Imaging Med Surg; 2024 Jul; 14(7):4840-4854. PubMed ID: 39022283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.